Joseph Schwartz Score: 23
Analyst at
Leerink Partners
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
-4.8%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
43%
6 W / 8 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
30%
3 W / 7 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
10%
1 W / 9 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
10%
1 W / 9 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
38%
5 W / 8 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
42%
5 W / 7 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
50%
1 W / 1 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| May 14, 2026 |
AN2 Therapeutics Inc
ANTX
|
BUY |
$9.00
Est. +109%
|
$4.31 | $5.24 |
Pending
|
$4.74
+10.0%
|
| Mar 12, 2026 |
Ultragenyx Pharmaceutical Inc.
RARE
|
BUY |
$60.00
Est. +181%
|
$21.36 | $27.40 |
Pending
|
$24.35
+14.0%
|
| Mar 02, 2026 |
uniQure N.V.
QURE
|
BUY |
$35.00
Est. +233%
|
$10.50 | $31.00 |
Pending
|
$27.57
+162.6%
|
| Dec 03, 2025 |
Design Therapeutics Inc
DSGN
|
BUY |
$14.00
Est. +57%
|
$8.94 | $17.25 |
Target Met
|
$10.97
+22.7%
|
| Sep 09, 2025 |
Sarepta Therapeutics Inc
SRPT
|
SELL |
$15.00
Est. +15%
|
$17.57 | $14.68 (Low) |
Precision Hit (±3%)
|
$15.31
+12.9%
|
| Jul 19, 2025 |
Sarepta Therapeutics Inc
SRPT
|
SELL |
$10.00
Est. +29%
|
$14.08 | $10.42 (Low) |
Pending
|
$15.31
-8.7%
|
| May 23, 2025 |
Fulcrum Therapeutics Inc
FULC
|
BUY |
$12.00
Est. +86%
|
$6.44 | $15.74 |
Target Met
|
$3.45
-46.4%
|
| Nov 06, 2024 |
Ultragenyx Pharmaceutical Inc.
RARE
|
BUY |
$85.00
Est. +66%
|
$51.20 | $53.47 |
Miss
|
$24.35
-52.4%
|
| Oct 16, 2024 |
Wave Life Sciences Ltd.
WVE
|
BUY |
$22.00
Est. +46%
|
$15.05 | $16.74 |
Miss
|
$5.87
-61.0%
|
| Sep 19, 2024 |
Edgewise Therapeutics Inc
EWTX
|
BUY |
$42.00
Est. +42%
|
$29.50 | $38.12 |
Miss
|
$34.83
+18.1%
|
| Sep 06, 2024 |
KalVista Pharmaceuticals Inc
KALV
|
BUY |
$20.00
Est. +55%
|
$12.87 | $16.32 |
Miss
|
$27.00
+109.8%
|
| Jul 03, 2024 |
AN2 Therapeutics Inc
ANTX
|
BUY |
$5.00
Est. +135%
|
$2.13 | $3.07 |
Miss
|
$4.74
+122.5%
|
| Jun 24, 2024 |
Solid Biosciences Inc
SLDB
|
BUY |
$12.00
Est. +81%
|
$6.62 | $10.37 |
Miss
|
$7.14
+7.9%
|
| Jun 20, 2024 |
Mereo Biopharma Group Plc - ADR
MREO
|
BUY |
$8.00
Est. +101%
|
$3.98 | $5.02 |
Miss
|
$0.31
-92.3%
|
AN2 Therapeutics Inc
ANTX
May 14, 2026
Signal & Target
BUY
$9.00
Start Price
$4.31
Best Price (1Y)
$5.24
Current Price
$4.74
Return
+10.0%
Ultragenyx Pharmaceutical Inc.
RARE
Mar 12, 2026
Signal & Target
BUY
$60.00
Start Price
$21.36
Best Price (1Y)
$27.40
Current Price
$24.35
Return
+14.0%
uniQure N.V.
QURE
Mar 02, 2026
Signal & Target
BUY
$35.00
Start Price
$10.50
Best Price (1Y)
$31.00
Current Price
$27.57
Return
+162.6%
Design Therapeutics Inc
DSGN
Dec 03, 2025
Signal & Target
BUY
$14.00
Start Price
$8.94
Best Price (1Y)
$17.25
Current Price
$10.97
Return
+22.7%
Sarepta Therapeutics Inc
SRPT
Sep 09, 2025
Signal & Target
SELL
$15.00
Start Price
$17.57
Best Price (1Y)
$14.68
Current Price
$15.31
Return
+12.9%
Sarepta Therapeutics Inc
SRPT
Jul 19, 2025
Signal & Target
SELL
$10.00
Start Price
$14.08
Best Price (1Y)
$10.42
Current Price
$15.31
Return
-8.7%
Fulcrum Therapeutics Inc
FULC
May 23, 2025
Signal & Target
BUY
$12.00
Start Price
$6.44
Best Price (1Y)
$15.74
Current Price
$3.45
Return
-46.4%
Ultragenyx Pharmaceutical Inc.
RARE
Nov 06, 2024
Signal & Target
BUY
$85.00
Start Price
$51.20
Best Price (1Y)
$53.47
Current Price
$24.35
Return
-52.4%
Wave Life Sciences Ltd.
WVE
Oct 16, 2024
Signal & Target
BUY
$22.00
Start Price
$15.05
Best Price (1Y)
$16.74
Current Price
$5.87
Return
-61.0%
Edgewise Therapeutics Inc
EWTX
Sep 19, 2024
Signal & Target
BUY
$42.00
Start Price
$29.50
Best Price (1Y)
$38.12
Current Price
$34.83
Return
+18.1%
KalVista Pharmaceuticals Inc
KALV
Sep 06, 2024
Signal & Target
BUY
$20.00
Start Price
$12.87
Best Price (1Y)
$16.32
Current Price
$27.00
Return
+109.8%
AN2 Therapeutics Inc
ANTX
Jul 03, 2024
Signal & Target
BUY
$5.00
Start Price
$2.13
Best Price (1Y)
$3.07
Current Price
$4.74
Return
+122.5%
Solid Biosciences Inc
SLDB
Jun 24, 2024
Signal & Target
BUY
$12.00
Start Price
$6.62
Best Price (1Y)
$10.37
Current Price
$7.14
Return
+7.9%
Mereo Biopharma Group Plc - ADR
MREO
Jun 20, 2024
Signal & Target
BUY
$8.00
Start Price
$3.98
Best Price (1Y)
$5.02
Current Price
$0.31
Return
-92.3%